Senior Director, Portfolio Integration Lead

Description

For candidates seeking to be located at our Stevenage site this role will temporarily be based ever the Company plans to relocate its offices to Cambridge UK. The location of this role will therefore subsequently change to Cambridge UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029.

Business Introduction
At GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edge technology to transform peoples lives. GSK fosters a culture ambitious for patients accountable for impact and committed to doing the right thing making sure that we focus our efforts on accelerating significant assets that meet patients needs and have the highest probability of success.

Were uniting science technology and talent to get ahead of disease together.
Find out more:
Our approach to R&D

Job Title:
Senior Director Portfolio Integration Lead

Overview

Cancer is unrelenting but so are we. At GSK we are committed to transforming outcomes for people with cancer through innovative science bold ambition and strong partnerships across the healthcare ecosystem. We focus our science where it can matter most - advancing care in cancers with high unmet need grounded in a deep understanding of disease biology and deliberate scientific choices that connect discovery to meaningful impact in the real world.

The Portfolio Integration Lead (PIL) is a senior role in Oncology Clinical Development responsible for shaping the advancement of multiple oncology programmes from our portfolio with a focus on particular cancers. Working closely with both the VP and Clinical Development Leads (CDLs) and cross-functional teams across GSK this role ensures scientific alignment portfolio coherence and development excellence across assets. This is a senior individual contributor position that operates across the full breadth of an Oncology portfolio rather than within a single programme enabling cross-asset integration and strategic alignment across development activities.

The PIL applies a disease-level clinical and scientific lens across the portfolio integrating disease biology biomarker strategy and emerging clinical approaches to define what is scientifically feasible and inform development pathways across programmes. This includes bringing clinical context to novel biomarker strategies and trial designs particularly for early-stage and mechanistically novel assets and across programmes with similar indications.

The position is open to candidates from either a medical or non-medical background based on the expertise required to be successful operating at the intersection of oncology disease strategy clinical development and portfolio leadership.

In This Role You Will:

• Provide senior scientific partnership to CDLs particularly in areas such as disease biology biomarker strategy and novel treatment combinations development.

• Ensure consistent cross-programme ways of working to improve development efficiency and execution.

• Drive cross-programme portfolio working groups and ensure business level alignment

• Drive and support clinical trial innovation based on evolving oncology treatment landscape government regulations basic/translational science and emerging technologies (such as AI-enabled tools).

• Strengthen the scientific and strategic positioning of a pan-asset portfolio across multiple clinical and pre-clinical assets.

• Drive initiatives that advance data and technology strategies supporting development decision-making.

• Shape engagement with external experts and governance bodies including advisory boards where relevant.

Key Responsibilities

Portfolio Strategy & Cross-Program Integration

• Shape the advancement of multiple development programs within the oncology portfolio by providing scientific insights across assets ensuring that agreed disease strategy is implemented consistently across programs.

• Prepare detailed strategic analyses and portfolio recommendations on behalf of the Disease Area Vice President enabling effective decision-making at senior leadership and governance levels.

• Ensure alignment and coordination across Clinical Matrix Teams (CMTs) and relevant cross-functional stakeholders in Research & Development (R&D) Global Medical Affairs (GMA) and Global Product Strategy (GPS).

• Drive disease-level…